Myeloproliferative neoplasm other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]

Overview

Other imaging studies for myeloproliferative neoplasm include positron emission tomography (PET) scan, which helps to detect metastasis in bone marrow and to follow up medical treatment.

PET scan

Positron emission tomography (PET) scan can be done to assess for hypermetabolic activity in bone marrow, lymph nodes, and other organs.^[1] PET scan can help diagnose an underlying malignancy associated with myeloproliferative neoplasm, such as lymphoma. PET scan can also assess for enlargement of the spleen and hypermetabolic activity in the spleen. Of note, a PET scan is not standard of care in patients with myeloproliferative neoplasm but can be of diagnostic utility if other imaging modalities, such as CT scan, are nondiagnostic.

References

↑ Agool A, Glaudemans AW, Boersma HH, Dierckx RA, Vellenga E, Slart RH (2011). “Radionuclide imaging of bone marrow disorders”. Eur J Nucl Med Mol Imaging. 38 (1): 166–78. doi:10.1007/s00259-010-1531-0. PMC 3005118. PMID 20625724.

Template:WH Template:WS

[pmid20625724-1] Agool A, Glaudemans AW, Boersma HH, Dierckx RA, Vellenga E, Slart RH (2011). “Radionuclide imaging of bone marrow disorders”. Eur J Nucl Med Mol Imaging. 38 (1): 166–78. doi:10.1007/s00259-010-1531-0. PMC 3005118. PMID 20625724.

[1]